CVS Health Corporation

CVS Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

87.65 0.09 −0.10%
Market cap
$112.0B
P/E
22.9×
Fwd P/E
15.4×
Dividend yield
3.79%
F-score
7/9
Altman Z
2.26
Beneish M
−2.64
Dividend safety
43/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
6.21% 3.79% 2.34% 0.63%

+8 more TTM periods

Piotroski F-Score
6 5 7 7
ROA
1.91% 1.15% 0.70% 0.18%
ROIC
4.07% 2.89% 2.25% 2.41%
Return on Tangible Assets
331.98% 202.49% (197.54%) (17.07%)
Average Days of Receivables
35.45 36.68 36.11 40.62
Free Cash Flow per Share
9.19 5.81 6.16 4.96
Free Cash Flow
11,758.00 7,394.00 7,807.00 6,293.00
Capital Expenditures
(3,022.00) (2,938.00) (2,832.00) (2,816.00)
Other line items
Cash ROIC
7.57% 4.85% 5.19% 4.19%
Accounts Receivable Turnover
10.25 10.12 10.55 9.85
Accounts Payable Turnover
13.39 13.48 13.19 12.99
Inventory Turnover
13.14 12.83 11.84 11.87
Average Days of Payables
27.19 27.38 29.11 29.83
Days of Inventory on Hand
27.92 28.76 31.76 31.84
Tax Rate
(0.16) (0.16) (0.19) (0.85)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Share Based Compensation of Revenue
0.17% 0.17% 0.13% 0.14%
Interest Coverage
2.67 1.92 1.49 1.59
Operating CF/Net income
3.02 3.52 6.02 19.42
Depreciation/Fixed assets
0.78 0.79 0.79 0.80
Capex/Depreciation
(0.29) (0.29) (0.27) (0.27)
Revenue per Share
324.54 320.43 317.34 310.55
Operating CF per Share
11.56 8.12 8.40 7.18
Capex per Share
(2.36) (2.31) (2.24) (2.22)
Capex to Sales
0.01 0.01 0.01 0.01

Fold the line items

Columns are period end dates